AstraZeneca competitorsClear all

Daiichi Sankyo's top competitors include Sanofi, Novartis, Bayer and Teva Pharmaceuticals.

	Daiichi Sankyo Daiichi Sankyo (第一三共株式会社) is a developer of pharmaceutical products.	Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Bayer Bayer is a global life science company specializing in healthcare and nutrition.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.
Founding Date	Founding Date 2005	Founding Date 2004	Founding Date 1996	Founding Date 1863	Founding Date 1901
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare cosmetics drug development oncology pharma	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech clinical research drug development pharma	Tags Agriculture Healthcare Manufacturing & Industrial agritech biotech conglomerates drug development health & beauty life sciences nutrition pharma	Tags Healthcare drug development pharma therapy
Locations	Locations Tokyo, JP HQ Wien, AT Braine L'alleud, BE Sao Paulo, BR São Paulo, BR Beijing, CN Shanghai, CN see more	Locations Paris, FR HQ Hydra, DZ Macquarie Park, AU Wien, AT Dhaka, BD Brussel, BE Geel, BE see more	Locations Basel, CH HQ Tirana, AL Bir Mourad Raïs, DZ Duc, AR Macquarie Park, AU Wien, AT Baku, AZ see more	Locations Leverkusen, DE HQ Tirana, AL Dely Ibrahim, DZ Luanda, AO Munro, AR Pymble, AU Wien, AT see more	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE São Paulo, BR Dupnica, BG see more
Employees	Employees 16,0334% increase	Employees 95,4424% decrease	Employees 110,0004% increase	Employees 99,6372% decrease	Employees 37,100
Valuation ($)	Valuation ($) 44.4 b	Valuation ($) 132.1 b	Valuation ($) N/A	Valuation ($) 65.3 b	Valuation ($) N/A
Twitter followers	Twitter followers 624	Twitter followers 147.8 k	Twitter followers 299.8 k	Twitter followers 183 k	Twitter followers 3.6 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 15	Number of tweets (last 30 days) 32	Number of tweets (last 30 days) 66	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 17.7	Average likes per tweet (last 30 days) 10.8	Average likes per tweet (last 30 days) 19.1	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 37.5%	Percentage of tweets with engagement (last 30 days) 62.12%	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 560867	Alexa Website Rank 178741	Alexa Website Rank 102511	Alexa Website Rank 77182	Alexa Website Rank 338084
Employee Rating	Employee Rating 3.9	Employee Rating N/A	Employee Rating N/A	Employee Rating 4.3	Employee Rating 3.6
Financial
Revenue (est.)	Revenue (est.) ¥962.5b (FY, 2021)	Revenue (est.) €37.8b (FY, 2021)	Revenue (est.) $52.9b (FY, 2021)	Revenue (est.) €44.1b (FY, 2021)	Revenue (est.) $16.7b (FY, 2020)
Cost of goods	Cost of goods (¥280.9b) (FY, 2021)	Cost of goods (€10.7b) (FY, 2021)	Cost of goods ($9.7b) (FY, 2021)	Cost of goods (€11.7b) (FY, 2021)	Cost of goods $8.9b (FY, 2020)
Gross profit	Gross profit ¥681.6b (FY, 2021)	Gross profit €28.9b (FY, 2021)	Gross profit $45.1b (FY, 2021)	Gross profit €33.6b (FY, 2021)	Gross profit $7.7b (FY, 2020)
Net income	Net income ¥75.8b (FY, 2021)	Net income €6.2b (FY, 2021)	Net income $24b (FY, 2021)	Net income €1b (FY, 2021)	Net income ($4.1b) (FY, 2020)
Operating ⚠
Patent Applications	Patent Applications 415 (Dec, 2020)	Patent Applications N/A	Patent Applications N/A	Patent Applications 48.1 k (FY, 2017)	Patent Applications N/A
Phase II Trials Products	Phase II Trials Products 7 (FY, 2019)	Phase II Trials Products N/A	Phase II Trials Products N/A	Phase II Trials Products 12 (Jan, 2020)	Phase II Trials Products N/A
Phase III Trials Products	Phase III Trials Products 7 (FY, 2019)	Phase III Trials Products N/A	Phase III Trials Products 54 (FY, 2021)	Phase III Trials Products 9 (Jan, 2020)	Phase III Trials Products N/A
Suppliers	Suppliers N/A	Suppliers 68 k (FY, 2019)	Suppliers N/A	Suppliers 86.4 k (FY, 2019)	Suppliers N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 310m	Total funding raised $ 6.5m	Total funding raised $ 3.5b	Total funding raised $ 358m